A case of interstitial lung disease with alveolar hemorrhage induced by pembrolizumab.

MLA

Sugano, Teppei, et al. “A Case of Interstitial Lung Disease with Alveolar Hemorrhage Induced by Pembrolizumab.” OncoTargets & Therapy, vol. 11, Sept. 2018, pp. 5879–83. EBSCOhost, https://doi.org/10.2147/OTT.S169321.

APA

Sugano, T., Seike, M., Noro, R., Kaburaki, S., Tozuka, T., Takahashi, A., Takano, N., Tanaka, T., Kashiwada, T., Takeuchi, S., Minegishi, Y., Saito, Y., Kubota, K., Terasaki, Y., & Gemma, A. (2018). A case of interstitial lung disease with alveolar hemorrhage induced by pembrolizumab. OncoTargets & Therapy, 11, 5879–5883. https://doi.org/10.2147/OTT.S169321

Chicago

Sugano, Teppei, Masahiro Seike, Rintaro Noro, Syota Kaburaki, Takehiro Tozuka, Akihiko Takahashi, Natsuki Takano, et al. 2018. “A Case of Interstitial Lung Disease with Alveolar Hemorrhage Induced by Pembrolizumab.” OncoTargets & Therapy 11 (September): 5879–83. doi:10.2147/OTT.S169321.